nasopharyngeal-carcinoma

Documents about nasopharyngeal-carcinoma

• The impact of radiation-induced temporal lobe injury on cognition and structure across the whole brain in nasopharyngeal carcinoma patients#5356Europe PMC
• Phase III Trial of EBV-DNA-Guided Adaptive Immunotherapy for Advanced Nasopharyngeal Carcinoma#836768ClinicalTrials.gov
• Carboplatin and Docetaxel Followed by Epstein-Barr Virus Cytotoxic T Lymphocytes#377407ClinicalTrials.gov
• GNT Induction Treatment in Locally Advanced NPC#993489ClinicalTrials.gov
• Novel Small Molecule EBNA1 Inhibitor, VK 2019, in Patients With Epstein Barr Virus (EBV)-Positive Nasopharyngeal Cancer (NPC) and Other Epstein-Barr Virus (EBV)-Associated Cancers, With Pharmacokinetic and Pharmacodynamic Correlative Studies#1032857ClinicalTrials.gov
• A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers#300257ClinicalTrials.gov
• Anrotinib and Tirelizumab in First-line Treatment of RM-NPC#136326ClinicalTrials.gov
• EBV strain interacts with host HLA to drive nasopharyngeal carcinoma risk.#219013NCBI PubMed Central
• Induction Chemotherapy Followed by Concurrent Chemoradiotherapy in Patients With LA-NPC#865936ClinicalTrials.gov
• Table 1_Efficacy and safety analysis of PD-1 inhibitors combined with chemoradiotherapy in the treatment of locally advanced nasopharyngeal carcinoma.docx#405484Figshare
• A Multi-center, Randomized, Double-blind, Phase II/III Clinical Trial of AK104 or Placebo in Combination With Chemotherapy as Second-line or More Lines for Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)#844610ClinicalTrials.gov
• Study of Combination of Sorafenib With Cisplatin and 5-fluorouracil as First-line Treatment of Recurrence After Radiotherapy Patients Who Failed With Radiotherapy in Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)#1032952ClinicalTrials.gov
• EBV-TCR-T（YT-E001）for Patients With EBV-positive Recurrent or Metastatic NPC#158234ClinicalTrials.gov
• CDK4/6 Inhibitor Plus Camrelizumab for PD-1 Inhibitor Refractory R/M NPC#245504ClinicalTrials.gov
• Systematic Review of AI-Driven Applications for Screening Nasopharyngeal Carcinoma Using MRI.#449853NCBI PubMed Central
• Transnasal Endoscopic Surgery Combined With Adjuvant Immunotherapy for Recurrent NPC#628540ClinicalTrials.gov
• Envafolimab Combined With Chemoradiotherapy and Recombinant Human Endostatin for LA-NPC.#845861ClinicalTrials.gov
• Supporting data for "A Multi-omics Study Reveals an Epigenomic Subtype Shapes a Pro-metastatic Niche in Epstein-Barr Virus-associated Nasopharyngeal Carcinoma"#387536Figshare
• Intranasal Corticosteroid Spray for Preventing Otitis Media With Effusion After Radiotherapy in Nasopharyngeal Carcinoma#839300ClinicalTrials.gov
• Time-dependent Diffusion MRI for Predicting Response to Induction Chemotherapy in Nasopharyngeal Carcinoma.#258139NCBI PubMed Central
• HARNESSING CD137 RECEPTOR/LIGAND SYSTEM TO RESHAPE TUMOUR IMMUNITY#348239ScholarBank@NUS
• Treatment of Cerebral Radiation Necrosis With GM1, a Prospective Study#813133ClinicalTrials.gov
• Xerostomia-optimised IMRT Versus Standard IMRT in NPC#991964ClinicalTrials.gov
• Topical Chlorhexidine Spray for the Prevention of Acute Radiation Dermatitis in Patients With Nasopharyngeal Carcinoma:#900659ClinicalTrials.gov
• Evaluation of the Sensitivity of Endoscopy to Detect Nasopharyngeal Carcinoma (NPC) in an Epstein-Barr Virus (EBV)-Based NPC Screening Project in China#842312ClinicalTrials.gov
• Validation of the 9th AJCC Staging System for NPC in Non-High-Incidence Areas in China#321721ClinicalTrials.gov
• Case Report: Pediatric nasopharyngeal carcinoma masquerading as benign lymphadenopathy: diagnostic pitfalls in two cases.#330888NCBI PubMed Central
• P-MES: Explainable pathology-based distant metastasis risk stratification in locally advanced nasopharyngeal carcinoma.#442889NCBI PubMed Central
• Prognostic value of radiation treatment time deviation in nasopharyngeal carcinoma receiving intensity-modulated radiotherapy.#481059NCBI PubMed Central
• Tegio Consolidation Therapy for NPC Patients With High Risk of Metastasis#845175ClinicalTrials.gov
• Verification of Harmonization of Plasma Epstein-Barr Virus DNA Measurements#907495ClinicalTrials.gov
• Trial of E10A in Head and Neck Cancer#877847ClinicalTrials.gov
• The expression of egfr and pegfr in nasopharyngeal carcinoma patients in HUSM#256577USM Repository
• Targeted or Chemotherapy Combined With Immunotherapy Versus Chemotherapy for PD-1 Inhibitor Refractory R/M NPC#283047ClinicalTrials.gov
• Prognostic Value of Platelet-Associated Biomarkers in Nasopharyngeal Carcinoma Patients Received IMRT: A Retrospective Study.#446045NCBI PubMed Central
• Investigation of clinical applicability of deep learning-based virtual contrast-enhanced MRI for nasopharyngeal carcinoma patients.#610367NCBI PubMed Central
• Baseline low prognostic nutritional index predicts poor survival in locally advanced nasopharyngeal carcinomas treated with radical concurrent chemoradiotherapy#955441Koc University Digital Collections
• Streptococcus Salivarius K12 for Prevention and Treatment of Oral Mucositis in Patients Undergoing Radiotherapy#908947ClinicalTrials.gov
• Longitudinal MRI Temporal Transformer Fusion Model for Predicting Induction Chemotherapy Efficacy in Locally Advanced Nasopharyngeal Carcinoma.#255251NCBI PubMed Central
• Early Nutritional Intervention in NPC Patients Undergoing Concurrent Chemoradiotherapy#898805ClinicalTrials.gov
• A Prospective, Randomized, Controlled Clinical Study of BET Combined With Tympanostomy Tube Insertion in the Treatment of Intractable OME After Radiotherapy for NPC#869686ClinicalTrials.gov
• Development and Validation of a Deep Learning Model to Predict Distant Metastases in Nasopharyngeal Carcinoma Using Whole Slide Imaging and MRI#866577ClinicalTrials.gov
• Brain alterations detected by multiplex magnetic resonance imaging in nasopharyngeal carcinoma patients after induction chemotherapy: a longitudinal study.#464971NCBI PubMed Central
• Pembrolizumab + MRGOO3 as Neoadjuvant in NPC#831322ClinicalTrials.gov
• Reducing Target Volumes in NPC Treated With Induction Chemotherapy Followed by Concurrent Chemoradiotherapy#890887ClinicalTrials.gov
• Tolinapant and Radiation for Cisplatin-Ineligible, Previously Untreated, Locally Advanced Head and Neck Cancer#807698ClinicalTrials.gov
• Evaluating the Optimal Timing of Acupuncture for Managing Chemoradiation-induced Xerostomia in Patients With Head and Neck Cancers#869628ClinicalTrials.gov
• Amifostine Plus Chemotherapy and Radiation Therapy in Treating Patients With Advanced, Unresectable Head and Neck Cancer#875322ClinicalTrials.gov
• Large-scale and high-resolution mass spectrometry-based proteomics defines molecular subtypes of nasopharyngeal carcinoma for therapeutic targeting.#308795NCBI PubMed Central
• CD70-targeted immunoPET Imaging of Malignant Cancers#847411ClinicalTrials.gov